|
Cells/tissues | Target | H2S donor(s) | Effects | Ref. |
|
Cutaneous vessels | COX and NO vasodilatory signalling pathway | NaHS and Na2S | Vasodilatation | [17] |
HaCaT cells | p38, MAPK, ERK, and NF-κB pathways | NaHS | Inhibit the TNF-α-mediated upregulation of NO, IL-6, and IL-8 | [7] |
HaCaT cells | ROS-activated NF-κB/COX-2 signalling pathway | NaHS | Inhibit chemical hypoxia-induced cytotoxicity and inflammation | [43] |
HaCaT cells | Autophagy | NaHS | Promote proliferation and differentiation | [25] |
Endothelial progenitor cell | Angiopoietin-1 | NaHS and 4-hydroxythiobenzamide | Improve diabetic wound healing | [47] |
Mouse skin | NETs and ROS-induced MAPK, ERK1/2, and p38 signaling pathways | Na2S | Improve diabetic wound healing | [51] |
Ischemic mouse adductor muscle | VEGF, EGF, PDGF, HIF-1α, and eNOS | Na2S | Promote ischemic diabetic wound healing | [52] |
Granulation tissues | VEGF | NaHS-containing ointment | Accelerate diabetic wound healing | [53] |
Primary human epidermal melanocytes | Melanogenic enzymes (MITF, TYR, and TRP-1) | NaHS | Promote cell proliferation and melanin synthesis | [8] |
Skin fibroblasts and keratinocytes | ROS and mitochondrial membrane potential | NaHS | Accelerate wound healing and improve blood flow | [65] |
Oral mucosa, peritoneal macrophages, and RAW264.7 cells | NF-κB signalling pathway | GYY4137 | Inhibit mucosal wound inflammation and accelerate wound healing | [66] |
Skin fibroblast cell lines (AG11395 and AG12795) | mTOR pathway | NaHS | Restore a normal morphologic phenotype | [74] |
Mouse skin and lung | α-Smooth muscle actin, collagen-I, collagen-III, fibronectin, TGF-β1, Smad2/3 | NaHS | Alleviate the severity of systemic sclerosis-associated skin and lung fibrosis | [75] |
A375 human melanoma | NF-κB, AKT/ERK pathways | DATS | Inhibit melanoma proliferation, invasion, and metastasis | [10] |
B16- F10 cells | AKT/ERK pathway | CSE substrate L-cysteine or DATS | Inhibit tumour growth | [10] |
A375 and SK-MEL-28 human melanoma | PI3K/AKT/mTOR pathway | NaHS | Inhibit tumour growth, migration, and cell cycle | [9] |
A375 and basal cell carcinoma cells | Cytosolic Ca2+, ROS, and mitochondrial membrane potential | DATS | Inhibit tumour growth | [77] |
A375 human melanoma | Integrin/FAK pathway | DATS | Inhibit cell migration and invasion | [78] |
A375 human melanoma | Caspase 3 | Naproxen-HBTA | Suppress human melanoma cell proliferation, migration, invasion, and colony formation | [79] |
|